COVID-19 Clinical Neuroscience Study (COVID-CNS) | C4C
The aim of the COVID-19 Clinical Neuroscience Study is to describe the neurological, psychiatric, and cognitive complications of COVID-19 and neurological, psychiatric and cognitive outcomes, to identify demographic, comorbid and clinical features associated with the development of these neurological, psychiatric and cognitive complications, and to determine the role of biomarkers of CNS injury, host immune response, and neuroimaging changes to identify biological mechanisms causing these complications in COVID-19 patients.